Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision to Offer DiaGenic Gene Expression Tests

NEW YORK (GenomeWeb News) – DiaGenic said today that lab services firm DNAVision will offer the firm’s blood-based gene expression tests for early detection of breast cancer and Alzheimer’s disease.
The Oslo-based molecular diagnostics firm said that DNAVision would offer the tests through its CLIA/ISO17025-certified facilities.
DiaGenic said it is in the process of introducing the breast cancer test in India. It expects to CE Mark the tests early next year and then seek clearance in the US sometime in the future.
“In parallel to this agreement, we are finalizing the distribution channels in preparation for a full European launch in early next year following CE marking of both the breast cancer and the Alzheimer’s disease test,” DiaGenic CEO Erik Christensen said in a statement.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.